Aberrant sonic hedgehog signaling pathway and STAT3 activation in papillary thyroid cancer

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 7, 2014, Pages 1786-1793

  Dong, Wenwu ^a   Cui, Junshuai ^a   Tian, Xinshuai ^a   He, Liang ^a   Wang, Zhihong ^a   Zhang, Ping ^a   Zhang, Hao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Hedgehog; Immunohistochemistry; p STAT3; Thyroid cancer

Indexed keywords

PROTEIN PATCHED; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR GLI1;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME; UPREGULATION;

EID: 84905657319     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762.
2. Shi Q, Li S, Jia J and Jiang J. The Hedgehog-induced Smoothened conformational switch assembles a signaling complex that activates Fused by promoting its dimerization and phosphorylation. Development 2011; 138: 4219-4231.
3. Oue T, Yoneda A, Uehara S, Yamanaka H and Fukuzawa M. Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg 2010; 45: 387-392.
4. Jiang J and Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008; 15: 801-812.
5. Wilson CW and Chuang PT. Mechanism and evolution of cytosolic Hedgehog signal transduction. Development 2010; 137: 2079-2094.
6. Briscoe J and Therond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol 2013; 14: 416-429.
7. Ingham PW and McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059-3087.
8. Kasper M, Regl G, Frischauf AM and Aberger F. GLI transcription factors: mediators of oncogenic Hedgehog signalling. Eur J Cancer 2006; 42: 437-445.
9. Hui M, Cazet A, Nair R, Watkins DN, O'Toole SA and Swarbrick A. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Res 2013; 15: 203.
10. Yang L, Xie G, Fan Q and Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010; 29: 469-481.
11. Bahra M, Kamphues C, Boas-Knoop S, Lippert S, Esendik U, Schuller U, Hartmann W, Waha A, Neuhaus P, Heppner F, Pietsch T and Koch A. Combination of hedgehog signaling blockage and chemotherapy leads to tumor reduction in pancreatic adenocarcinomas. Pancreas 2012; 41: 222-229.
12. Lyseng-Williamson KA and Keating GM. Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma. Am J Clin Dermatol 2013; 14: 61-64.
13. Sansone P and Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 2012; 30: 1005-1014.
14. Frank DA. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007; 251: 199-210.
15. Yang Q, Shen SS, Zhou S, Ni J, Chen D, Wang G and Li Y. STAT3 activation and aberrant liganddependent sonic hedgehog signaling in human pulmonary adenocarcinoma. Exp Mol Pathol 2012; 93: 227-236.
16. Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R and Banerjee S. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007; 21: 949-955.
17. Zhang M, Zhu W and Li Y. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening. Eur J Med Chem 2013; 62: 301-310.
18. Sansone P and Bromberg J. Environment, inflammation, and cancer. Curr Opin Genet Dev 2011; 21: 80-85.
19. Mete O, Rotstein L and Asa SL. Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 2010; 17: 386-391.
20. Edge SB and Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
21. Kim KH, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Chung YS and Kim SH. Expression of sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium. Pathol Int 2009; 59: 279-287.
22. Ruiz i Altaba A, Sanchez P and Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002; 2: 361-372.
23. Fagman H, Grande M, Gritli-Linde A and Nilsson M. Genetic deletion of sonic hedgehog causes hemiagenesis and ectopic development of the thyroid in mouse. Am J Pathol 2004; 164: 1865-1872.
24. Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T and Konishi I. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis. Cancer Sci 2007; 98: 68-76.
25. Ding YL, Wang QS, Zhao WM and Xiang L. Expression of smoothened protein in colon cancer and its prognostic value for postoperative liver metastasis. Asian Pac J Cancer Prev 2012; 13: 4001-4005.
26. Xu X, Ding H, Rao G, Arora S, Saclarides CP, Esparaz J, Gattuso P, Solorzano CC and Prinz RA. Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer 2012; 19: 167-179.
27. Nelson KK, Gattuso P, Xu X and Prinz RA. Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy. Surgery 2010; 148: 654-660; discussion 660.
28. Bohinc B, Michelotti G and Diehl AM. Hedgehog signaling in human medullary thyroid carcinoma: a novel signaling pathway. Thyroid 2013; 23: 1119-1126.
29. Hinterseher U, Wunderlich A, Roth S, Ramaswamy A, Bartsch DK, Hauptmann S, Greene BH, Fendrich V and Hoffmann S. Expression of hedgehog signalling pathway in anaplastic thyroid cancer. Endocrine 2014; 45: 439-47.
30. Mori Y, Okumura T, Tsunoda S, Sakai Y and Shimada Y. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology 2006; 70: 378-389.
31. Cavicchioli Buim ME, Gurgel CA, Goncalves Ramos EA, Lourenco SV and Soares FA. Activation of sonic hedgehog signaling in oral squamous cell carcinomas: a preliminary study. Hum Pathol 2011; 42: 1484-1490.
32. Kim TJ, Lee JY, Hwang TK, Kang CS and Choi YJ. Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups. J Surg Oncol 2011; 104: 472-479.
33. Chen XL, Cheng QY, She MR, Wang Q, Huang XH, Cao LQ, Fu XH and Chen JS. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro. Arch Med Res 2010; 41: 315-323.
34. He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, Zhu JG, Jiang FN and Zhong WD. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res 2012; 18: 349-355.
35. Devarajan E and Huang S. STAT3 as a central regulator of tumor metastases. Curr Mol Med 2009; 9: 626-633.
36. Kim WG, Choi HJ, Kim WB, Kim EY, Yim JH, Kim TY, Gong G, Kim SY, Chung N and Shong YK. Basal STAT3 activities are negatively correlated with tumor size in papillary thyroid carcinomas. J Endocrinol Invest 2012; 35: 413-418.
37. Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simoes M, Lima J, Maximo V, Soares P, Lyden D and Bromberg JF. STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A 2012; 109: E2361-2370.
38. Hwang JH, Kim DW, Suh JM, Kim H, Song JH, Hwang ES, Park KC, Chung HK, Kim JM, Lee TH, Yu DY and Shong M. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. Mol Endocrinol 2003; 17: 1155-1166.
39. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008; 21 Suppl 2: S37-43.
40. Lang SA, Schachtschneider P, Moser C, Mori A, Hackl C, Gaumann A, Batt D, Schlitt HJ, Geissler EK and Stoeltzing O. Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Mol Cancer Ther 2008; 7: 3509-3518.
41. Wei Z, Jiang X, Qiao H, Zhai B, Zhang L, Zhang Q, Wu Y, Jiang H and Sun X. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cell Signal 2013; 25: 931-938.
42. Matsuda T, Junicho A, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H and Muraguchi A. Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells. Biochem Biophys Res Commun 2001; 283: 179-187.